Země: Velká Británie
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Carvedilol
Viatris UK Healthcare Ltd
C07AG02
Carvedilol
25mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000; GTIN: 5016695000145
OBJECT 1 CARVEDILOL 25 MG FILM-COATED TABLETS Summary of Product Characteristics Updated 10-May-2017 | Generics UK T/A Mylan 1. Name of the medicinal product Carvedilol 25 mg Film-coated Tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 25 mg carvedilol Excipient with known effect: Each film-coated tablet contains 100 mg: lactose monohydrate For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet 25 mg film-coated tablets: white, oval, scored on both sides and marked "25" on one side. The 25mg tablets can be divided into equal doses. 4. Clinical particulars 4.1 Therapeutic indications • Essential hypertension. • Chronic stable angina pectoris • Adjunctive treatment in moderate to severe stable heart failure. 4.2 Posology and method of administration Carvedilol is available in 4 strengths: 3.125 mg, 6.25 mg, 12.5 mg and 25 mg ESSENTIAL HYPERTENSION: Carvedilol may be used for the treatment of hypertension alone or in combination with other antihypertensives, especially thiazide diuretics. Once daily dosing is recommended, however the recommended maximum single dose is 25 mg and the recommended maximum daily dose is 50 mg. Adults: The recommended initial dose is 12.5 mg once a day for the first two days. Thereafter, the treatment is continued at the dose 25 mg/day. If necessary, the dose may be further increased gradually at intervals of at least two weeks. Elderly: The recommended initial dose in hypertension is 12.5 mg once a day, which may also be sufficient for continued treatment. However, if the therapeutic response is inadequate at this dose, the dose may be further increased gradually at intervals of at least two weeks. CHRONIC STABLE ANGINA PECTORIS Adults: The recommended initial dose is 12.5 mg twice daily for two days. Thereafter, the treatment is continued at the dose 25 mg twice daily. If necessary, the dose may be further increased gradually at intervals of at least two weeks. The recommended maximum daily dose is 100 mg in Přečtěte si celý dokument